Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Mar 19, 2025
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-03-18$1.50/sh−13,047$19,623→ 1,571,962 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.